Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 21-30 of 63 for Lymphoma

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Study To Assess BMS-986458 Alone And In Combination With Anti-lymphoma Agents In Relapsed/Refractory Non-Hodgkin Lymphomas

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. A Dose-Escalation And Expansion Study Of BGB-16673 In Participants With B-Cell Malignancies

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. DALY II USA/ MB-CART2019.1 For DLBCL

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. Ascorbic Acid And Chemotherapy For The Treatment Of Relapsed Or Refractory Lymphoma, CCUS, And Chronic Myelomonocytic Leukemia

    Eau Claire, WI, La Crosse, WI, Mankato, MN, Rochester, MN

  5. AZD0486 As Monotherapy In Participants With Relapsed/Refractory (R/R) B-cell NHL

    Rochester, MN

  6. A Study Of LY4152199 In Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

    Rochester, MN

  7. Global Trial In APG2575 For Patients With CLL/​SLL

    Jacksonville, FL

  8. Study Of Tirabrutinib Vs Rituximab/Temozolomide For Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. Wearable Artificial InTelligence For Cardiac Function And Health Monitoring

    Rochester, MN

  10. A Study Of ABBV-383 With Relapsed Refractory Waldenström Macroglobulinemia

    Rochester, MN

.

Mayo Clinic Footer